Business Watch: Fuller to Buy Wound-Care Company AMS; Novartis, Antares Ink Agreement for Cancer Small Molecules
Fuller plans to acquire wound-care company AMS, while Novartis and Antares agree on cancer small molecules; the report notes hardware stores remain key outlets for chemical products despite retail con
cen · 2026-06-30 00:00 UTC